Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

New England Journal of Medicine

Volumn 339, Issue 23, 1998, Pages 1649-1656

  Cassileth, Peter A ^a   Harrington, David P ^b   Appelbaum, Frederick R ^c   Lazarus, Hillard M ^d   Rowe, Jacob M ^e   Paietta, Elisabeth ^f   Willman, Cheryl ^g   Hurd, David D ^h   Bennett, John M ^e   Blume, Karl G ⁱ   Head, David R ^j   Wiernik, Peter H ^f  

^a UNIVERSITY OF MIAMI   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f MONTEFIORE MEDICAL CENTER   (United States)

^g UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^h WAKE FOREST SCHOOL OF MEDICINE   (United States)

ⁱ STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^j ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; HLA ANTIGEN; IDARUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED STUDY; GENOTYPE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; BONE MARROW TRANSPLANTATION; CYTARABINE; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, MYELOID; MIDDLE AGED; REMISSION INDUCTION; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032480930     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199812033392301     Document Type: Article

References (33)

1. Weinstein HJ, Griffin JD. Acute myelogenous leukemia. In: Handin RI, Lux SE, Stossel TP, eds. Blood: principles & practice of hematology. Philadelphia: J.B. Lippincott, 1995:543-74.
2. Leith CP, Kopecky KJ, Godwin J, et al. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDRl) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses for standard chemotherapy: a Southwest Oncology Group study. Blood 1997; 89:3323-9.
3. Cassileth PA, Harrington DP, Hines JD, et al. Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia. J Clin Oncol 1988;6:583-7.
4. Mayer RJ, Davis RB, Schiffer CA, et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 1994;31: 896-903.
5. Cassileth PA, Lynch E, Hines JD, et al. Varying intensity of postremission therapy in acute myeloid leukemia. Blood 1992;79:1924-30.
6. Schiller G, Gajewski J, Territo M, et al. Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia. Blood 1992;80:2977-82.
7. Dinsmore R, Kirkpatrick D, Flomenberg N, et al. Allogeneic bone marrow transplantation for patients with acute nonlymphocytic leukemia. Blood 1984;63:649-56.
8. Copelan EA, Biggs JC, Thompson JM, et al. Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2. Blood 1991;78:838-43.
9. Schiller GJ, Nimer SD, Territo MC, Ho WG, Champlin RE, Gajewski JL. Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission. J Clin Oncol 1992;10:41-6.
10. Lowenberg B, Verdonck LJ, Dekker AW, et al. Autologous bone marrow transplantation in acute myeloid leukemia in first remission: results of a Dutch prospective study. J Clin Oncol 1990;8:287-94.
11. Sierra J, Brunet S, Granena A, et al. Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. J Clin Oncol 1996;14:1353-63.
12. Schiller G, Mittal-Henkle A, Lill M, Lee M, Territo M. Transplantation of autologous peripheral blood progenitor cells procured after high-dose cytarabine/G-CSF based consolidation for adults with acute myelogenous leukemia in first remission. Blood 1995;86:Suppl 1:99a. abstract.
13. Stein AS, O'Donnell MR, Chai A, et al. In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission. J Clin Oncol 1996;14:2206-16.
14. Cassileth PA, Andersen J, Lazarus HM, et al. Autologous bone marrow transplant in acute myeloid leukemia in first remission. J Clin Oncol 1993;11:314-9.
15. Zittoun RA, Mandelli F, Willemze R, et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med 1995;332:217-23.
16. Burnett AK, Goldstone AH, Stevens RMF, et al. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. Lancet 1998;351:700-8.
17. Harousseau JL, Cahn JY, Pignon B, et al. Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. Blood 1997;90:2978-86.
18. Ravindranath Y, Yeager AM, Chang MN, et al. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. N Engl J Med 1996;334:1428-34.
19. Woods WG, Neudorf S, Gold S, et al. Aggressive post-remission chemotherapy is better than autologous bone marrow transplantation (BMT) and allogeneic BMT is superior to both in children with acute myeloid leukemia. Proc Am Soc Clin Oncol 1996;15:368a. abstract.
20. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukemias: French-American-British (FAB) Co-operative Group. Br J Haematol 1976;33:451-8.
21. Idem. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med 1985;103:620-5.
22. Dastugue N, Payen C, Lafage-Pochitaloff M, et al. Prognostic significance of karyotype in de novo adult acute myeloid leukemia. Leukemia 1995;9:1491-8.
23. Rosenfeld C, Shadduck RK, Przepiorka D, Mangan KF, Colvin M. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for acute nonlymphocytic leukemia in late remission or early relapse. Blood 1989;74:1159-64.
24. Yeager AM, Kaizer H, Santos GW, et al. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med 1986;315:141-7
25. Cheson BD, Cassileth PA, Head DR, et al. Report of the National Cancer Institute sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990;8:813-9.
26. Berkson J, Gage RP. Survival curves for cancer patients following treatment. J Am Stat Assoc 1952;47:501-15.
27. Prentice RL. Linear rank tests with right censored data. Biometrika 1978;65:167-79.
28. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979;35:549-56.
29. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
30. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
31. Cox DR, Sneel EJ. The analysis of binary data. 2nd ed. New York: Chapman & Hall, 1989.
32. Sanz MA, de la Rubia J, Sanz GF, et al. Busulfan plus cyclophosphamide followed by autologous blood stem-cell transplantation for patients with acute myeloblastic leukemia in first complete remission: a report from a single institution. J Clin Oncol 1993;11:1661-7.
33. Linker CA, Ries CA, Damon LE, et al. Autologous stem cell transplantation for acute myeloid leukemia in first remission. Blood 1995;86: Suppl 1:99a. abstract.